JP2025503704A5 - - Google Patents

Info

Publication number
JP2025503704A5
JP2025503704A5 JP2024542028A JP2024542028A JP2025503704A5 JP 2025503704 A5 JP2025503704 A5 JP 2025503704A5 JP 2024542028 A JP2024542028 A JP 2024542028A JP 2024542028 A JP2024542028 A JP 2024542028A JP 2025503704 A5 JP2025503704 A5 JP 2025503704A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
fusion protein
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024542028A
Other languages
English (en)
Japanese (ja)
Other versions
JP7884072B2 (ja
JP2025503704A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/060582 external-priority patent/WO2023137395A1/en
Publication of JP2025503704A publication Critical patent/JP2025503704A/ja
Publication of JP2025503704A5 publication Critical patent/JP2025503704A5/ja
Application granted granted Critical
Publication of JP7884072B2 publication Critical patent/JP7884072B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024542028A 2022-01-13 2023-01-12 Vegf及びtie2を結合する融合タンパク質並びにその使用 Active JP7884072B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263299177P 2022-01-13 2022-01-13
US63/299,177 2022-01-13
US202263310359P 2022-02-15 2022-02-15
US63/310,359 2022-02-15
US202263335805P 2022-04-28 2022-04-28
US63/335,805 2022-04-28
PCT/US2023/060582 WO2023137395A1 (en) 2022-01-13 2023-01-12 Vegf and tie2-binding fusion protein and uses thereof

Publications (3)

Publication Number Publication Date
JP2025503704A JP2025503704A (ja) 2025-02-04
JP2025503704A5 true JP2025503704A5 (cg-RX-API-DMAC7.html) 2025-05-02
JP7884072B2 JP7884072B2 (ja) 2026-07-02

Family

ID=87279731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024542028A Active JP7884072B2 (ja) 2022-01-13 2023-01-12 Vegf及びtie2を結合する融合タンパク質並びにその使用

Country Status (16)

Country Link
US (1) US20230287109A1 (cg-RX-API-DMAC7.html)
EP (1) EP4463482A4 (cg-RX-API-DMAC7.html)
JP (1) JP7884072B2 (cg-RX-API-DMAC7.html)
KR (1) KR20250005053A (cg-RX-API-DMAC7.html)
AU (1) AU2023206363A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242904A1 (cg-RX-API-DMAC7.html)
CL (2) CL2024002106A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024010934A2 (cg-RX-API-DMAC7.html)
CR (1) CR20240342A (cg-RX-API-DMAC7.html)
DO (1) DOP2024000136A (cg-RX-API-DMAC7.html)
GE (1) GEAP202416581A (cg-RX-API-DMAC7.html)
IL (1) IL314219A (cg-RX-API-DMAC7.html)
JO (1) JOP20240158A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024008737A (cg-RX-API-DMAC7.html)
PE (1) PE20260003A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023137395A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250128899A (ko) * 2024-02-20 2025-08-28 주식회사 맵틱스 Tie2 및 VEGF에 특이적으로 결합하는 이중 특이적 항체 및 이의 용도
WO2026036282A1 (en) * 2024-08-13 2026-02-19 Pentavision Biosciences Limited Multispecific fusion proteins targeting angiogenic factors
US20260226178A1 (en) * 2024-12-23 2026-08-06 Ingenia Therapeutics, Inc. Fusion Proteins Comprising a Tie2 Binding Domain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3415533A1 (en) * 2011-08-19 2018-12-19 Regeneron Pharmaceuticals, Inc. Anti-tie2 antibodies uses thereof
JP2020501508A (ja) * 2016-09-15 2020-01-23 クアドルセプト バイオ リミテッド 多量体、四量体および八量体
JP2021507723A (ja) * 2017-12-05 2021-02-25 ユニバーシティ オブ ワシントンUniversity of Washington 視細胞における治療遺伝子の機能的発現を増強するための組成物および方法
WO2019235856A1 (ko) * 2018-06-07 2019-12-12 기초과학연구원 Tie2에 결합하는 항체 및 이의 용도
EP3805265A4 (en) * 2018-06-07 2022-07-06 Institute for Basic Science ANTIBODIES BINDING TO TIE2 AND USES THEREOF
JP2021529557A (ja) * 2018-06-29 2021-11-04 ジェンサン バイオファーマ、 インコーポレイテッドGensun Biopharma, Inc. 抗腫瘍免疫チェックポイント調節因子アンタゴニスト
JP7249060B2 (ja) * 2018-08-17 2023-03-30 トリカン・バイオテクノロジー・カンパニー・リミテッド 抗血管新生融合タンパク質およびその使用
EP3856245A4 (en) 2018-09-24 2022-10-26 EyePoint Pharmaceuticals, Inc. MULTISPECIFIC ANTIBODIES AGAINST HPTP - BETA (VE-PTP) AND VEGF
AU2020385991A1 (en) * 2019-11-21 2022-06-23 Unity Biotechnology Antibodies directed to Tie-2 and methods of use
CA3169967A1 (en) * 2020-03-24 2021-09-30 Genentech, Inc. Tie2-binding agents and methods of use

Similar Documents

Publication Publication Date Title
US20220363771A1 (en) Multispecific antibodies
TWI689518B (zh) 特異性結合人il-17a的分離的單株抗體
EP2414391B1 (en) Multispecific antibodies comprising full length antibodies and single chain fab fragments
TW202126694A (zh) 標靶cd3的抗體、雙特異性抗體及其用途
JP2019528051A (ja) 修飾抗原結合Fab断片及びこれを含む抗原結合分子
AU2011311673B2 (en) Antibodies against human TWEAK and uses thereof
CN106573986A (zh) 多特异性抗体
WO2010112194A1 (en) Antigen-binding polypeptides and multispecific antibodies comprising them
JP5596777B2 (ja) ヒトtweakに対する抗体とその使用
JP2025508317A5 (cg-RX-API-DMAC7.html)
JP2025504909A5 (cg-RX-API-DMAC7.html)
KR20220167331A (ko) 항-flt3 항체 및 조성물
CN114846026B (zh) 对人il-13和il-17具有结合特异性的多特异性抗体
CN114790246A (zh) 一种抗体及其用途
US12404326B2 (en) Bivalent bispecific antibody and preparation method thereof, coding gene, host cell and composition
RU2025118544A (ru) Белки, связывающие рецепторы трансферрина
RU2026105457A (ru) Антитела к белку а-бета, способы и их применения
HK40069078A (en) Multi-specific antibody with binding specificity for human il-13 and il-17
HK1167669B (en) Multispecific antibodies comprising full length antibodies and single chain fab fragments
EA043309B1 (ru) Биспецифические конструкции антител, вовлекающие т-клетки